Thrivent Financial for Lutherans Purchases 740 Shares of Maximus, Inc. (NYSE:MMS)

Thrivent Financial for Lutherans lifted its position in Maximus, Inc. (NYSE:MMSFree Report) by 0.1% in the 2nd quarter, Holdings Channel.com reports. The fund owned 794,595 shares of the health services provider’s stock after acquiring an additional 740 shares during the period. Thrivent Financial for Lutherans’ holdings in Maximus were worth $68,097,000 at the end of the most recent quarter.

A number of other large investors have also recently made changes to their positions in MMS. Assenagon Asset Management S.A. lifted its stake in Maximus by 151.6% in the second quarter. Assenagon Asset Management S.A. now owns 233,134 shares of the health services provider’s stock worth $19,980,000 after purchasing an additional 140,481 shares during the last quarter. Healthcare of Ontario Pension Plan Trust Fund purchased a new stake in shares of Maximus in the first quarter worth approximately $2,601,000. Tidal Investments LLC lifted its stake in shares of Maximus by 238.9% during the 1st quarter. Tidal Investments LLC now owns 12,763 shares of the health services provider’s stock worth $1,071,000 after acquiring an additional 8,997 shares during the last quarter. SG Americas Securities LLC boosted its holdings in Maximus by 609.6% during the 2nd quarter. SG Americas Securities LLC now owns 14,278 shares of the health services provider’s stock valued at $1,224,000 after acquiring an additional 12,266 shares during the period. Finally, Entropy Technologies LP bought a new position in Maximus in the 1st quarter valued at $491,000. 97.21% of the stock is owned by hedge funds and other institutional investors.

Maximus Stock Down 0.6 %

NYSE:MMS opened at $89.98 on Friday. The company has a market cap of $5.47 billion, a price-to-earnings ratio of 23.62 and a beta of 0.76. Maximus, Inc. has a twelve month low of $72.39 and a twelve month high of $93.97. The company has a current ratio of 1.59, a quick ratio of 1.59 and a debt-to-equity ratio of 0.61. The stock has a fifty day simple moving average of $89.80 and a 200-day simple moving average of $86.14.

Maximus (NYSE:MMSGet Free Report) last announced its quarterly earnings data on Wednesday, August 7th. The health services provider reported $1.74 earnings per share for the quarter, beating analysts’ consensus estimates of $1.47 by $0.27. The company had revenue of $1.31 billion during the quarter, compared to analyst estimates of $1.29 billion. Maximus had a net margin of 5.59% and a return on equity of 20.91%. The firm’s revenue for the quarter was up 10.6% on a year-over-year basis. During the same quarter last year, the business posted $0.78 EPS. Analysts anticipate that Maximus, Inc. will post 6.12 EPS for the current year.

Maximus Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Saturday, August 31st. Investors of record on Thursday, August 15th were paid a $0.30 dividend. The ex-dividend date was Thursday, August 15th. This represents a $1.20 annualized dividend and a yield of 1.33%. Maximus’s dividend payout ratio (DPR) is currently 31.50%.

About Maximus

(Free Report)

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.

Featured Stories

Want to see what other hedge funds are holding MMS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Maximus, Inc. (NYSE:MMSFree Report).

Institutional Ownership by Quarter for Maximus (NYSE:MMS)

Receive News & Ratings for Maximus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus and related companies with MarketBeat.com's FREE daily email newsletter.